{"id":"W2002606479","doi":"10.1007/s00280-012-2008-6","title":"Sunitinib combined with pemetrexed and cisplatin: results of a phase I dose-escalation and pharmacokinetic study in patients with advanced solid malignancies, with an expanded cohort in non-small cell lung cancer and mesothelioma","year":2012,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital","funders":"Pfizer","keywords":"Pemetrexed; Medicine; Sunitinib; Tolerability; Cisplatin; Lung cancer; Pharmacokinetics; Internal medicine; Mesothelioma; Oncology; Response Evaluation Criteria in Solid Tumors; Dosing; Pharmacology; Chemotherapy; Phases of clinical research; Cancer; Adverse effect; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001956183,0.001586962,0.003194192,0.000684934,0.0005918759,0.001160454,0.0008943353,0.001021592,0.001708012],"category_scores_gemma":[0.001747092,0.0008294829,0.002046639,0.0009397814,0.001074829,0.001832656,0.0003688811,0.003134283,0.0004401682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001401598,"about_ca_system_score_gemma":0.0012029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463214,"about_ca_topic_score_gemma":0.002910672,"domain_scores_codex":[0.9991276,0.0003662547,0.00004835705,0.0002070785,0.00009687689,0.0001539551],"domain_scores_gemma":[0.998853,0.0002745639,0.0002535971,0.000154816,0.00006001498,0.0004040388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7352242,0.05363683,0.04338948,0.0003895375,0.003694928,0.0003432664,0.0006660779,0.007718976,0.04256281,0.0002014813,0.002213061,0.1099593],"study_design_scores_gemma":[0.3404695,0.4752339,0.1619407,0.00003359156,0.002627581,0.001005203,0.000280884,0.005603106,0.009593483,0.000344113,0.002744644,0.000123277],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987186,0.0005195221,0.0001018901,0.00008826899,0.00001708661,0.0001104865,0.0002048778,0.00002563774,0.0002135673],"genre_scores_gemma":[0.997871,0.0005319009,0.0003913296,0.000110694,0.00005283125,0.0001311396,0.0005358961,0.00002255609,0.000352614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003194192,"threshold_uncertainty_score":0.0103454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01194540249692799,"score_gpt":0.3474005889607801,"score_spread":0.3354551864638521,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}